Clinical TrialsSearch results
Number of results: 865
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase 3 study of gemcitabine and S-1 compared with gemcitabine monotherapy in patients with unresectable advanced pancreatic cancer.
- pancreatic cancer
- Chiba Cancer Center
- 2009-07-24
Recruiting
- A Phase 3 Study of Nemtabrutinib vs Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) for 1L CLL/SLL
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Fujita Tomoko
- 2024-03-13
Other
- A Phase 3 Study of Sotatercept in Japanese PAH Participants
- Pulmonary Arterial Hypertension (PAH)
- Tanaka Yoshiyuki
- 2023-04-21
Other
- A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults with Familial Chylomicronemia Syndrome
- Familial Chylomicronemia Syndrome (FCS)
- Hokonohara Toshihiro
- 2022-08-07
Completed
- A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Parsaclisib Plus Investigator's Choice of Either Rituximab or Obinutuzumab in Participants With Relapsed or Refractory Follicular Lymphoma and Marginal Zone Lymphoma
- Follicular Lymphoma (FL) , Marginal Zone Lymphoma (MZL)
- Ueda Eiji
- 2021-09-05
Other
- A Phase 3, Randomized, Open-label Study for Participants with Later-lines of Metastatic Colorectal Cancer by Bristol-Myers Squibb
- microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
- Marimuthu Sathiya
- 2022-07-31
No Longer Recruiting
- A Phase I Study of CYT001
- Hepatocellular carcinoma
- Kato Naoya
- 2019-08-08
Other
- A Phase I study of iPS-NKT cell intra-arterial infusion therapy in patients with recurrent or advanced head and neck cancer
- Patients with recurrent or advanced head and neck squamous cell carcinoma
- Iinuma Tomohisa
- 2020-09-11
Other
- A phase I study of niraparib and pimitespib in patients with solid tumor
- unresectable recurrent solid tumor
- Naito Yoichi
- 2022-07-02
Recruiting
- A Phase I study of Oxyfedrine and Sulfasalazine in Patients with Solid Tumor
- advanced or recurrent solid tumor unresectable and unresponsive to conventional therapy
- Kohei Shitara
- 2023-12-22